InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the complete record of transactions filed by Daruwala Paul, Chief Operating Officer. Insider active across 1 company, notably Cidara Therapeutics, Inc.. In total, 4 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €11k. Activity tracked since 30 September 2021. The latest transaction was filed on 12 September 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Daruwala Paul
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
16,199 shares@ US$0.6849100.0% of flowCommon StockSEC:0001610618-22-000076:0
50,000 shares0Common StockSEC:0001610618-22-000019:0
9,900 shares0Common StockSEC:0001209191-22-002604:0
132,000 shares0Common StockSEC:0001610618-21-000091:0
4 of 4 declarations
About Daruwala Paul
Paul Daruwala serves as the Chief Operating Officer of Cidara Therapeutics, Inc. In this role, he is responsible for managing the daily operations of the company. Paul brings expertise in operational management and strategy, enabling him to effectively lead Cidara's initiatives. His experience contributes to the efficiency and performance of the company.
